Sato, Toshihiro, Masamitsu Maekawa, Nariyasu Mano, Takaaki Abe, and Hiroaki Yamaguchi. 2021. “Role of OATP4C1 in Renal Handling of Remdesivir and Its Nucleoside Analog GS-441524: The First Approved Drug for Patients With COVID-19”. Journal of Pharmacy & Pharmaceutical Sciences 24 (May):227-36. https://doi.org/10.18433/jpps31813.